odprn logo ODPRN

Recent Research

First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario

This study examines the use of first-line alcohol use disorder (AUD) medications (naltrexone and acamprosate) among public drug plan beneficiaries in the year following an AUD diagnosis.

Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma: An umbrella review

To inform policy recommendations on the use of immunotherapy in Ontario, the ODPRN performed a rapid umbrella review of existing systematic reviews that assessed the benefits and harms of allergen immunotherapy for treatment of allergic rhinitis or asthma.

Blood glucose test strip quantity limits across Canada

Provincial governments across Canada have implemented blood glucose test strip (BGTS) quantity limits to encourage proper testing practices for optimal patient outcomes. The ODPRN has developed a provincial list of implementation details for each province as of May 2017.

Latest trends in opioid-related deaths in Ontario: 1991 to 2015

This report describes the trends in opioid-related deaths, the opioids involved in each death, and the characteristics of individuals who died of an opioid-related cause in Ontario up to the end of 2015.

Additional Resources


Please note that this report is NOT COMPLETE and is still in progress. Click below if you would like to continue.